Dr. Wagner and the CureDuchenne team provided information about Santhera Pharmaceuticals' expanded access and compassionate use in the U.S., the BreatheDMD program, and Santhera answered questions from the community.
In a webinar on November 16, 2017, Dr. Eric Olson from University of Texas Southwestern Medical Center explained CRISPR technology and gene therapy for Duchenne.
This webinar provided an update from Santhera Pharmaceuticals about the SIDEROS trial of idebenone in boys taking steroids. Santhera also provided an update about their regulatory efforts to bring this treatment to boys with Duchenne in the US and Europe.
This webinar addressed what the Duchenne community needs to know about EMFLAZACares™ by sharing an overview of this service program which is providing personalized support and resources to help gain access to EMFLAZA™.
A webinar about “Newly Released Data on EMFLAZA vs Prednisone” presented by Dr. Craig McDonald, UC Davis Health, and hosted by CureDuchenne.